Advanced Glycation End Products Enhance Osteoclast-Induced Bone Resorption in Cultured Mouse Unfractionated Bone Cells and in Rats Implanted Subcutaneously with Devitalized Bone Particles

Journal of the American Society of Nephrology

Volumn 8, Issue 2, 1997, Pages 260-270

  Miyata, Toshio ^a   Notoya, Kohei ^b   Yoshida, Keiji ^b   Horie, Katsunori ^c   Maeda, Kenji ^c   Kurokawa, Kiyoshi ^a   Taketomi, Shigehisa ^b  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

^c NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; BETA 2 MICROGLOBULIN; CALCITONIN; IPRIFLAVONE; ISOFLAVONE DERIVATIVE;

AMYLOIDOSIS; ANIMAL; ARTICLE; BONE TRANSPLANTATION; CELL CULTURE; DRUG EFFECT; HUMAN; IN VITRO STUDY; MALE; MOUSE; OSTEOCLAST; OSTEOLYSIS; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; RENAL REPLACEMENT THERAPY; SPRAGUE DAWLEY RAT; URINE;

AMYLOIDOSIS; ANIMALS; BETA 2-MICROGLOBULIN; BONE RESORPTION; BONE TRANSPLANTATION; CALCITONIN; CELLS, CULTURED; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; ISOFLAVONES; MALE; MICE; OSTEOCLASTS; RATS; RATS, SPRAGUE-DAWLEY; RENAL DIALYSIS;

EID: 0031065827     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Brownlee M, Cerami A, Vlassara H: Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318: 1315-1321, 1988
2. Baynes JW, Monnier VM: The Maillard reaction in aging, diabetes and nutrition. Prog Clin Biol Res 304: 1-410, 1989
3. Kirstein M, Brett J, Radoff S, Ogawa S, Stern D, Vlassara H: Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: Role in vascular disease of diabetes and aging. Proc Natl Acad Sci USA 87: 9010-9014, 1990
4. Vlassara H, Brownlee M, Manogue KR, Dinarello CA, Pasagian A: Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling. Science 240: 1546-1548, 1988
5. Skolnik EY, Yang Z, Makita Z, Radoff S, Kirstein M, Vlassara H: Human and rat mesangial cell receptors for glucose-modified proteins: Potential role in kidney tissue remodelling and diabetic nephropathy. J Exp Med 174: 931-939, 1991
6. Doi T, Vlassara H, Kirstein M, Yamada Y, Striker GE, Striker LJ: Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor. Proc Natl Acad Sci USA 89: 2873-2877, 1992
7. Miyata T, Inagi R, Iida Y, Sato M, Yamada N, Osa O, Maeda K, Seo H: Involvement of β2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis: Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-α and interleukin 1. J Clin Invest 93: 521-528, 1994
8. Iida Y, Miyata T, Inagi R, Sugiyama S, Maeda K: β2-Microglobulin modified with advanced glycation end products induces interleukin-6 from human macrophages: Role in the pathogenesis of hemodialysis-associated amyloidosis. Biochem Biophys Res Commun 201: 1235-1241, 1994
9. Neeper M, Schmidt AM, Brett J, Yan SD, Wang F, Pan YC, Elliston K, Stern D, Shaw A: Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 267: 14998-15004, 1992
10. Schmidt AM, Yan SD, Brett J, Mora R, Nowygrod R, Stern D: Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products. J Clin Invest 92: 2155-2168, 1993
11. Baynes JW: Perspectives in diabetes: Role of oxidative stress in development of complications in diabetes. Diabetes 40: 405-412, 1991
12. Yan SD, Schmidt AM, Anderson GM, Zhang J, Brett J, Zou YS, Pinsky D, Stern D: Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem 269: 9889-9897, 1994
13. Bucala R, Makita Z, Vega G, Grundy S, Koschinsky T, Cerami A, Vlassara H: Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency. Proc Natl Acad Sci USA 91: 9441-9445, 1994
14. Miyata T, Oda O, Inagi R, Iida Y, Araki N, Yamada N, Horiuchi S, Taniguchi N, Maeda K, Kinoshita T: β2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. J Clin Invest 92: 1243-1252, 1993
15. Miyata T, Taneda S, Kawai R, Ueda Y, Horiuchi S, Hara M, Maeda K, Monnier VM: Identification of pentosidine as a native structure for advanced glycation end products in β2-microglobulin forming amyloid fibrils in patients with dialysis-related amyloidosis. Proc Natl Acad Sci USA 93: 2353-2358, 1996
16. Miyata T, Inagi R, Wada Y, Ueda Y, Iida Y, Takahashi M, Taniguchi N, Maeda K: Glycation of human β2-microglobulin in patients with hemodialysis-associated amyloidosis: Identification of the glycated sites. Biochemistry 33: 12215-12221, 1994
17. Miyata T, Iida Y, Ueda Y, Shinzato T, Seo H, Monnier VM, Maeda K: Monocyte/macrophage response to β2-microglobulin modified with the advanced glycation end products. Kidney Int 49: 538-550, 1996
18. Smith MA, Taneda S, Richey PL, Miyata S, Yan SD, Stern D, Sayre LM, Monnier VM, Perry G: Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc Natl Acad Sci USA 91: 5710-5714, 1994
19. Vitek MP, Bhattacharya K, Glendening JM, Stopa E, Vlassara H, Bucala R, Manogue K, Cerami A: Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc Natl Acad Sci USA 91: 4766-4770, 1994
20. Yan SD, Yan FF, Chen X, Jin F, Chen M, Kuppusamy P, Smith MA, Perry G, Godman GC, Nawroth P, Zweier JL, Stern D: Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid β-peptide. Nature Med 1: 693-699, 1995
21. Dr̈eke TB: Beta-2-microglobulin amyloidosis and renal bone disease. Miner Electrolyte Metab 17: 261-272, 1991
22. Koch KM: Dialysis-related amyloidosis. Kidney Int 41: 1416-1429, 1992
23. Makita Z, Radoff S, Rayfield EJ, Yang Z, Skolnik E, Delaney V, Friedman EA, Cerami A, Vlassara H: Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med 325: 836-842, 1990
24. Dyer DG, Dunn JA, Thorpe SR, Bailie KE, Lyons TJ, McCance DR, Baynes JW: Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J Clin Invest 91: 2463-2469, 1993
25. Suda T, Takahashi N, Martin TJ: Modulation of osteoclast differentiation. Endocrine Rev 13: 66-80, 1992
26. Sell DR, Monnier VM: Structure elucidation of a senescence cross-link from human extracellular matrix. J Biol Chem 264: 21597-21602, 1989
27. Odetti P, Forgarty J, Sell DR, Monnier VM: Chromatographic quantitation of plasma and erythrocyte pentosidine in diabetic and uremic subjects. Diabetes 41: 153-159, 1992
28. Takada Y, Kusuda M, Hiura K, Sato T, Mochizuki H, Nagao Y, Tomura M, Yashiro M, Hakeda Y, Kawashima H, Kumegawa M: A simple method to assess osteoclast-mediated bone resorption using unfractionated bone cells. Bone Min 17: 347-359, 1992
29. Burstone MS: Histochemical demonstration of acid phosphatase with naphthol AS-phosphate. J Natl Cancer Inst 21: 523-539, 1958
30. Notoya K, Yoshida K, Taketomi S, Yamazaki I, Kumegawa M: Inhibitory effect of ipriflavone on osteoclast-mediated bone resorption and new osteoclast formation in long-term cultures of mouse unfractionated bone cells. Calcif Tissue Int 53: 206-209, 1993
31. Takahashi N, Udagawa N, Akatsu T, Tanaka H, Shionome M, Suda T: Role of colony-stimulating factors in osteoclast development. J Bone Miner Res 6: 977-985, 1991
32. Takahashi N, Yamana H, Yoshiki S, Roodman DG, Mundy GR, Jones SJ, Boyde A, Suda T: Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures. Endocrinology 122: 1373-1382, 1988
33. Takahashi N, Akatsu T, Udagawa N, Sasaki T, Yamaguchi A, Moseley JM, Martin TJ, Suda T: Osteoblastic cells are involved in osteoclast formation. Endocrinology 123: 2600-2602, 1988
34. Lian JB, Tassinari M, Glowacki J: Resorption of implanted bone prepared from normal and warfarin-treated rats. J Clin Invest 73: 1223-1226, 1984
35. Wronski TJ, Yen C-F, Burton KW, Mehta RC, Newman PS, Soltis EE, Deluca PP: Skeletal effects of calcitonin in ovariectomized rats. Endocrinology 129: 2246-2250, 1991
36. Reginster JY: Effect of calcitonin on bone mass and fracture rates. Am J Med 91[Suppl 5B]: 19S-22S, 1991
37. Reginster JY: Ipriflavone pharmacological properties and usefulness in postmenopausal osteoporosis. Bone Min 23: 223-232, 1993
38. Akatsu T, Takahashi N, Udagawa N, Imamura K, Yamaguchi A, Sato K, Nagata N, Suda T: Role of prostaglandins in interleukin-1-induced bone resorption in mice in vitro. J Bone Miner Res 6: 183-189, 1991
39. McSheehy PMJ, Chambers TJ: Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone. Endocrinology 118: 824-828, 1986
40. McSheehy PMJ, Chambers TJ: Osteoblast-like cells in the presence of parathyroid hormone release soluble factor that stimulates osteoclastic bone resorption. Endocrinology 119: 1654-1659, 1986
41. 3 stimulates rat osteoblastic cells to release a soluble factor that increases osteoclastic bone resorption. J Clin Invest 80: 425-429, 1987
42. Pokharna HK, Monnier VM, Boja B, Moskowitz RW: Lysyl oxidase and Maillard reaction-mediated crosslinks in aging and osteoarthritic rabbit cartilage. J Orthop Res 13: 13-21, 1995
43. van Ypersele de Strihou C, Honhon B, Vandenbroucke JM, Huaux JP, Noel H, Maldague B: Dialysis amyloidosis. Adv Nephrol 17: 401-422, 1988
44. Gejyo F, Yamada T, Odani S, Nakagawa Y, Arakawa M, Kunitonmo T, Kataoka H, Suzuki M, Hirasawa Y, Shirahama T, Cohen AS, Schmid K: A new form of amyloid protein associated with chronic hemodialysis was identified as β2-microglobulin. Biochem Biophys Res Commun 129: 701-706, 1985
45. Gorevic PD, Munoz PC, Casey TT, DiRaimondo CR, Stone WJ, Prelli FC, Rodrigues MM, Poulik MD, Frangione B: Polymerization of intact β2-microglobulin in tissue causes amyloidosis in patients on chronic hemodialysis. Proc Natl Acad Sci USA 83: 7908-7912, 1986
46. Kahn AJ, Fallon MD, Teitelbaum SL: Structure-function relationships in bone: An examination of events at the cellular level. In: Bone and Mineral Research, edited by Peck WA, Amsterdam, Elsevier, 1984, pp 125-174
47. Yoshida K, Tsukamoto T, Tanayama S, Uemura I, Shibata K: Disposition of ipriflavone (TC-80) in rats and dogs. Radioisotopes 34: 618-623, 1985